Job title: Scientist
Title: Solid Tumor Target Selection For Successful Development of BiTE® (Bispecific T Cell Engager) Molecules
- Review case studies of select targets, focused on target expression analysis and preclinical safety
- Discuss target characteristics that impact potential for successful development
Dr. Elizabeth Pham holds a Ph.D in Biomedical Engineering from the University of Toronto and performed post-doctoral research at Sunnybrook Research Institute prior to joining Amgen Inc. as a Scientist in Immuno-Oncology. She currently heads a research group at Amgen focused on target discovery and BiTE molecule development for solid tumors.